Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO) (BUTYCLO)
Primary Purpose
Rectal Cancer
Status
Completed
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Irrigations trough the efferent limb of loop ileostomy
Sponsored by
About this trial
This is an interventional prevention trial for Rectal Cancer focused on measuring Ileostomy closure, Butyrate enemas, Microbiota, Rectal Cancer
Eligibility Criteria
Inclusion Criteria:
- Patients over 18 years of age
- Patients waiting for an elective ileostomy reversal after Rectal cancer surgical treatment
Exclusion Criteria:
- Inflammatory bowel disease
- Abnormal preoperative findings trough rectoscopy or CT-enema scan that precluded a safe ileostomy closure
- Ileal pouch, poor treatment compliance
- Pregnancy or lactation
- Unwillingness to use adequate contraception throughout the study period
- Combined surgeries
- The impossibility to understand the informed consent.
Sites / Locations
- Hospital Universitari Dr. Josep Trueta de Girona
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
Sham Comparator
Arm Label
Non-irrigations
Butyrate irrigations
Saline irrigations
Arm Description
No irrigations trough the efferent limb of loop ileostomy
Butyrate irrigations trough the efferent limb of loop ileostomy
Saline irrigations trough the efferent limb of loop ileostomy
Outcomes
Primary Outcome Measures
Postoperative complication rate
Rate of medical and surgical complications within 30 days after surgery using the Dindo-Clavien classification, described as:
Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.
Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.
Length of hospital stay (number of days)
Total length of hospital stay will be recorded in days beginning at admission for surgery until discharge.
Secondary Outcome Measures
Diversion colitis evaluation trough rectoscopy in colonic mucosa
Diversion colitis was graded as follows: Grade 0: Normal mucosa, Grade 1: Erythematous mucosa, Grade 2: Erythema and mucosa edema and Grade 3: Spontaneous bleeding or bleeding with the slightest contact with rectoscopy
Identification of microbiota modifications in colonic mucosa after irrigations
Sequences of the variable portions of the 16s ribosomal RNA gene
Quality of life assessed with Short-Form 36 (SF-36) questionnaire
This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health. Score from 0-100
Anorectal functional outcome assessed by Colorectal Functional Outcome Questionnaire (COREFO) questionnaire
Alterations in Colorectal Functional Outcome Questionnaire (COREFO) scores. Score from 0-27
Full Information
NCT ID
NCT04795180
First Posted
February 22, 2021
Last Updated
March 10, 2021
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
1. Study Identification
Unique Protocol Identification Number
NCT04795180
Brief Title
Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO)
Acronym
BUTYCLO
Official Title
Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients: Short-term Outcomes and Microbiota (BUTYCLO)
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
December 10, 2013 (Actual)
Primary Completion Date
May 17, 2016 (Actual)
Study Completion Date
June 21, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Low Anterior resection with total mesorectal excision and diversion loop ileostomy is a gold standard surgical treatment in rectal cancer.
Ileostomy reversal performed in a second stage carries a high burden of postoperative complications.
Terminal ileum and colon dysfunction during bowel disconnection could negatively influence postoperative morbimortality after loop ileostomy reversal in Rectal Cancer patients.
Colonic microflora performs anaerobic breakdown of dietary fibre that reaches the gut in regular patients without ileostomy. One of the short-chain fatty acids (SCFAs) produced by bacteria is butyrate, the preferred substrate to be oxidized by colonocytes.
The effects of butyrate irrigations before ileostomy closure on colonic mucosa will be studied in 45 rectal cancer patients.
The effects of butyrate irrigation trough the efferent limb of loop ileostomy before its closure will be compared to the saline and non-irrigations group.
Short term outcomes, colonic microbiota composition and functional outcomes will be evaluated after ileostomy reversal.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer
Keywords
Ileostomy closure, Butyrate enemas, Microbiota, Rectal Cancer
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Masking Description
1 treatment arm open label
1 treatment arm double-blind
1 treatment arm double-blind
Allocation
Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Non-irrigations
Arm Type
No Intervention
Arm Description
No irrigations trough the efferent limb of loop ileostomy
Arm Title
Butyrate irrigations
Arm Type
Experimental
Arm Description
Butyrate irrigations trough the efferent limb of loop ileostomy
Arm Title
Saline irrigations
Arm Type
Sham Comparator
Arm Description
Saline irrigations trough the efferent limb of loop ileostomy
Intervention Type
Drug
Intervention Name(s)
Irrigations trough the efferent limb of loop ileostomy
Intervention Description
Irrigations trough the efferent limb of loop ileostomy during 4 weeks previous to ileostomy closure
Primary Outcome Measure Information:
Title
Postoperative complication rate
Description
Rate of medical and surgical complications within 30 days after surgery using the Dindo-Clavien classification, described as:
Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.
Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.
Time Frame
Within 90 days after surgery
Title
Length of hospital stay (number of days)
Description
Total length of hospital stay will be recorded in days beginning at admission for surgery until discharge.
Time Frame
Up to 4 weeks
Secondary Outcome Measure Information:
Title
Diversion colitis evaluation trough rectoscopy in colonic mucosa
Description
Diversion colitis was graded as follows: Grade 0: Normal mucosa, Grade 1: Erythematous mucosa, Grade 2: Erythema and mucosa edema and Grade 3: Spontaneous bleeding or bleeding with the slightest contact with rectoscopy
Time Frame
At 5-weeks before surgery, At day before surgery
Title
Identification of microbiota modifications in colonic mucosa after irrigations
Description
Sequences of the variable portions of the 16s ribosomal RNA gene
Time Frame
At 5-weeks before surgery, At day before surgery
Title
Quality of life assessed with Short-Form 36 (SF-36) questionnaire
Description
This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health. Score from 0-100
Time Frame
At hospital discharge and at 1 and 3 months after surgery
Title
Anorectal functional outcome assessed by Colorectal Functional Outcome Questionnaire (COREFO) questionnaire
Description
Alterations in Colorectal Functional Outcome Questionnaire (COREFO) scores. Score from 0-27
Time Frame
At hospital discharge and at 1 and 3 months after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients over 18 years of age
Patients waiting for an elective ileostomy reversal after Rectal cancer surgical treatment
Exclusion Criteria:
Inflammatory bowel disease
Abnormal preoperative findings trough rectoscopy or CT-enema scan that precluded a safe ileostomy closure
Ileal pouch, poor treatment compliance
Pregnancy or lactation
Unwillingness to use adequate contraception throughout the study period
Combined surgeries
The impossibility to understand the informed consent.
Facility Information:
Facility Name
Hospital Universitari Dr. Josep Trueta de Girona
City
Girona
ZIP/Postal Code
17001
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO)
We'll reach out to this number within 24 hrs